Nuo Therapeutics Inc (AURX)
0.75
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Nuo Therapeutics Price to Book Value: 101.46 for June 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 14, 2024 | 101.46 |
| June 13, 2024 | 101.46 |
| June 12, 2024 | 100.11 |
| June 11, 2024 | 121.75 |
| June 10, 2024 | 121.75 |
| June 07, 2024 | 101.46 |
| June 06, 2024 | 101.46 |
| June 05, 2024 | 101.46 |
| June 04, 2024 | 101.46 |
| June 03, 2024 | 101.46 |
| May 31, 2024 | 101.45 |
| May 30, 2024 | 101.46 |
| May 29, 2024 | 101.46 |
| May 28, 2024 | 102.88 |
| May 24, 2024 | 105.52 |
| May 23, 2024 | 105.52 |
| May 22, 2024 | 105.52 |
| May 21, 2024 | 101.46 |
| May 20, 2024 | 101.46 |
| May 17, 2024 | 99.51 |
| May 16, 2024 | 99.51 |
| May 15, 2024 | 99.51 |
| May 14, 2024 | 99.51 |
| May 13, 2024 | 106.14 |
| May 10, 2024 | 106.14 |
| Date | Value |
|---|---|
| May 09, 2024 | 106.14 |
| May 08, 2024 | 106.14 |
| May 07, 2024 | 106.01 |
| May 06, 2024 | 106.01 |
| May 03, 2024 | 106.01 |
| May 02, 2024 | 106.14 |
| May 01, 2024 | 106.14 |
| April 30, 2024 | 106.14 |
| April 29, 2024 | 106.14 |
| April 26, 2024 | 106.14 |
| April 25, 2024 | 106.14 |
| April 24, 2024 | 106.14 |
| April 23, 2024 | 106.14 |
| April 22, 2024 | 106.14 |
| April 19, 2024 | 106.14 |
| April 18, 2024 | 106.14 |
| April 17, 2024 | 99.51 |
| April 16, 2024 | 126.04 |
| April 15, 2024 | 126.04 |
| April 12, 2024 | 126.04 |
| April 11, 2024 | 126.04 |
| April 10, 2024 | 126.04 |
| April 09, 2024 | 126.04 |
| April 08, 2024 | 126.04 |
| April 05, 2024 | 126.04 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0047
Minimum
Dec 31 2021
133.16
Maximum
Jun 30 2023
45.11
Average
34.94
Median
Oct 02 2023
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 5.566 |
| Perspective Therapeutics Inc | 2.898 |
| Protalix BioTherapeutics Inc | 2.806 |
| Electromed Inc | 2.954 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 40.94 |
| Price | 0.75 |
| Earnings Yield | -10.67% |
| Market Cap | 33.83M |